| The traditional Chinese medicine industry is closely linked to the physical and mental health of the people.It has a time-honored tradition and far-reaching international influence,and it is also an important support for building a healthy China.With the current aging degree of Chinese population,the improvement of people’s living standards and the concept of "cure disease" health care deeply rooted in people’s hearts;The comprehensive promotion of the pharmaceutical reform,the institutionalization and normalization of the development of the pharmaceutical industry has compressed the profit space,opportunities and challenges coexist.The competition among enterprises has changed from the competition of product and enterprise scale to the competition of profit model in line with their own development.In this process,some enterprises try to apply the asset-light profit model to obtain profits with "light" assets such as brand,marketing and research and development,and achieve initial results,such as Pien Tze Huang,Yunnan Baiyao,Tong Ren Tang,etc.However,there are still unsolved problems in their operation and management.The value chain carries out the whole process of enterprise production and management,and the ultimate purpose is to help enterprises better realize value creation.This paper studies the asset-light mode of enterprises from the perspective of value chain,puts forward optimization suggestions for the existing problems of enterprises,and helps enterprises optimize the application of asset-light mode and improve the ability of value creation.The asset-light mode of Pien Tze Huang has significant effect,and the results obtained by taking Pien Tze Huang as the research object have high reference value.First of all,based on relevant literature,theories,the company’s annual report and the collection,reading and sorting of relevant financial data,this paper analyzes Pien Tze Huang’s data from 2017 to 2021.It is concluded that the asset-light mode attaches importance to the investment of high value-added links,low proportion of fixed assets,rich cash reserves,mainly endogenous financing and high proportion of non-interest bearing liabilities.Secondly,from the perspective of value chain,through industry comparison,it is found that Pien Tze Huang has problems and shortcomings in four links: R&D innovation,manufacturing,marketing and brand value.Finally,after elaborating the necessity and feasibility of the construction of the value chain,optimization suggestions and safeguard measures are proposed for the research and development,production,sales and brand of Pien Tze Huang from the perspective of the value chain.The study on the application of the asset-light profit model of Pien Tze Huang can alleviate the current development pressure and provide direction for its future development.It can also provide reference for other pharmaceutical enterprises applying the asset-light model and promote the development of traditional Chinese medicine industry to a certain extent.At the same time,it can enrich the asset-light profit model and provide reference for other researches. |